Charlotte Allerton, Head of Discovery and Early Development at Pfizer joins Paul Biondi, Flagship Executive Partner and President of Pioneering Medicines, for a discussion about pioneering partnerships that leverage capabilities from across the biopharma industry to develop potentially transformational therapeutics, including the strategic alliance between Pfizer and 蘑菇视频APP.
More from:
Human Health
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Three Questions with Volker Herrmann, Flagship CEO-Partner & CEO of Sonata Therapeutics
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support
Letter of Support of H.R. 766, The Preventative Health Savings Act
